Ten year results of conservative surgery and irradiation for stage I and II breast cancer.

[1]  R. Arriagada,et al.  Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  B. Fowble,et al.  Definitive irradiation for early stage breast cancer: The University of Pennsylvania experience. , 1988, International journal of radiation oncology, biology, physics.

[3]  A. Luini,et al.  Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. , 1990, Annals of surgery.

[4]  P. Vielh,et al.  Local control and survival of breast cancer treated by limited surgery followed by irradiation. , 1986, International journal of radiation oncology, biology, physics.

[5]  C. Balch,et al.  Does radical mastectomy still have a place in the treatment of primary operable breast cancer? , 1987, Archives of surgery.

[6]  J. Jacquemier,et al.  Local recurrence after breast‐conserving surgery and radiotherapy. Frequency, time course, and prognosis , 1989, Cancer.

[7]  C. Redmond,et al.  Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Clark,et al.  Breast Cancer Experiences with Conservation Therapy , 1987, American journal of clinical oncology.

[9]  Jay R. Harris,et al.  Cosmetic results following primary radiation therapy for early breast cancer , 1984, Cancer.

[10]  S. Schnitt,et al.  Predictors of local recurrence following conservative breast surgery and radiation therapy. The influence of tumor size. , 1990, Archives of surgery.

[11]  H. Høst,et al.  Postoperative radiotherapy in breast cancer--long-term results from the Oslo study. , 1986, International journal of radiation oncology, biology, physics.

[12]  N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[13]  H. Høst Postoperative radiotherapy in breast cancer. , 1981, British medical journal.

[14]  A. Luini,et al.  Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. , 1986, European journal of cancer & clinical oncology.

[15]  B. Pierquin,et al.  The Past and Future of Conservative Treatment of Breast Cancer , 1986, American journal of clinical oncology.

[16]  G. Bonadonna,et al.  Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast cancer. , 1986, NCI monographs : a publication of the National Cancer Institute.

[17]  J. Vilcoq,et al.  Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. , 1989, International journal of radiation oncology, biology, physics.

[18]  B Fisher,et al.  Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. , 1985, The New England journal of medicine.

[19]  R. Arriagada,et al.  Conservative management of breast cancer , 1986, The British journal of surgery.

[20]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[21]  C. Bressac,et al.  The prognostic significance of late local recurrence after breast-conserving therapy. , 1990, International journal of radiation oncology, biology, physics.

[22]  S. Schnitt,et al.  Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer. , 1988, International journal of radiation oncology, biology, physics.

[23]  L. Venet,et al.  Prognostic factors in patients undergoing curative irradiation for breast cancer. , 1985, International journal of radiation oncology, biology, physics.

[24]  C. Redmond,et al.  A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. , 1989, The New England journal of medicine.

[25]  C. Redmond,et al.  Eight-year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer , 1989 .

[26]  C. Coleman,et al.  Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure. , 1989, International journal of radiation oncology, biology, physics.

[27]  C. Bressac,et al.  Why are local recurrences after breast-conserving therapy more frequent in younger patients? , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  B Fisher,et al.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. , 1989, The New England journal of medicine.

[29]  E. van Limbergen,et al.  Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  F. Ames,et al.  Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer , 1989, Cancer.

[31]  L. Skoog,et al.  Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials. , 1989, International journal of radiation oncology, biology, physics.

[32]  H Pujol,et al.  Tumorectomy and radiotherapy in early breast cancer: a report on 392 patients. , 1988, International journal of radiation oncology, biology, physics.

[33]  W. Gerald,et al.  Conservative surgery and radiation therapy in breast carcinoma: local recurrence and prognostic implications. , 1989, International journal of radiation oncology, biology, physics.

[34]  B Fisher,et al.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. , 1985, The New England journal of medicine.

[35]  E van der Schueren,et al.  Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. , 1992, Journal of the National Cancer Institute. Monographs.

[36]  C. Perez,et al.  Irradiation as the primary management of stage I and II adenocarcinoma of the breast: analysis of the RTOG breast registry. , 1980, Cancer clinical trials.

[37]  S. Schnitt,et al.  Factors associated with local recurrence as a first site of failure following the conservative treatment of early breast cancer. , 1989, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[38]  J. Kurtz,et al.  Conservation treatment of early breast cancer: long term results and complications. , 1987, International journal of radiation oncology, biology, physics.

[39]  J. Lefranc,et al.  Wide excision of the tumor, axillary dissection, and postoperative radiotherapy as treatment of small breast cancers , 1984, Cancer.

[40]  A. Martinez,et al.  Intra-arterial infusion of radiosensitizer (BUdR) combined with hypofractionated irradiation and chemotherapy for primary treatment of osteogenic sarcoma. , 1985, International journal of radiation oncology, biology, physics.

[41]  S Hellman,et al.  Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. , 1979, International journal of radiation oncology, biology, physics.

[42]  J. Vilcoq,et al.  Conservative treatment of early breast cancer: prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-term results. , 1989, European journal of cancer & clinical oncology.